Use of thienopyridine prior to presentation with non-ST-segment elevation acute coronary syndrome and association with safety and efficacy of vorapaxar: insights from the TRACER trial-Reference-Cited by-同舟云学术

Use of thienopyridine prior to presentation with non-ST-segment elevation acute coronary syndrome and association with safety and efficacy of vorapaxar: insights from the TRACER trial

Published:2016-09-20 Issue:2 Volume:6 Page:155-163
ISSN:2048-8726
Container-title:European Heart Journal: Acute Cardiovascular Care
language:en
Short-container-title:European Heart Journal: Acute Cardiovascular Care

Author:

Harskamp Ralf E¹,Clare Robert M²,Ambrosio Giuseppe³,Held Claes⁴,Lokhnygina Yuliya²,Moliterno David J⁵,White Harvey D⁶,Aylward Philip E⁷,Armstrong Paul W⁸,Mahaffey Kenneth W⁹,Harrington Robert A⁹,Van de Werf Frans¹⁰,Wallentin Lars⁴,Strony John¹¹¹²,Tricoci Pierluigi²

Affiliation:

1. Heart Center, Academic Medical Center, University of Amsterdam, Amsterdam, The Netherlands

2. Duke Clinical Research Institute, Durham, NC, USA

3. Division of Cardiology, University of Perugia School of Medicine, Perugia, Italy

4. Department of Medical Sciences, Uppsala Clinical Research Center, Uppsala University, Uppsala, Sweden

5. Gill Heart Institute and Division of Cardiovascular Medicine, University of Kentucky, Lexington, KY, USA

6. Green Lane Cardiovascular Service, Auckland City Hospital and Auckland University, Auckland, New Zealand

7. SAHMRI, Flinders University and Medical Centre, Adelaide, Australia

8. Division of Cardiology, University of Alberta, Edmonton, Canada

9. Department of Medicine, Stanford University, Stanford, CA, USA

10. Department of Cardiology, University Hospitals, Leuven, Belgium

11. Johnson & Johnson, New Brunswick, NJ, USA

12. Merck, Whitehouse Station, NJ, USA

Publisher

Oxford University Press (OUP)

Subject

Cardiology and Cardiovascular Medicine,Critical Care and Intensive Care Medicine,General Medicine

Link

http://journals.sagepub.com/doi/pdf/10.1177/2048872616633880

Reference10 articles.

1. Effects of Clopidogrel in Addition to Aspirin in Patients with Acute Coronary Syndromes without ST-Segment Elevation

2. Prasugrel versus Clopidogrel in Patients with Acute Coronary Syndromes

3. Ticagrelor versus Clopidogrel in Patients with Acute Coronary Syndromes

4. Discovery of Potent Orally Active Thrombin Receptor (Protease Activated Receptor 1) Antagonists as Novel Antithrombotic Agents

5. Thrombin-Receptor Antagonist Vorapaxar in Acute Coronary Syndromes

Cited by 1 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Protease-Activated Receptor-1 Antagonists Post-Percutaneous Coronary Intervention;Interventional Cardiology Clinics;2017-01